Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹7,132 Cr
up ₹240 Cr vs Jan 2024
- Stocks held
- 31
- down 1 vs Jan 2024
- Top 10 weight
- 59.1%
- of the portfolio in its ten largest
- Cash & debt
- 2.1%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 16
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In February 2024 it disclosed 31 stocks worth ₹7,132 Cr, up ₹240 Cr from Jan 2024. Its largest positions were Sun Pharmaceutical Industries Limited (14.5%), Lupin Limited (8.4%), Cipla Limited (6.4%); the ten largest together made up 59.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.9% of its equity. Cash and debt stood at 2.1%. Compared with Jan 2024 the fund entered 0 new stocks and exited 1.
Against 226 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
16%
Holds more stocks than 16% of peers
Cash
30%
Holds more cash than 30% of peers
Holdings in February 2024
Download CSVEvery line the fund disclosed, with the change against Jan 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 14.51%
- Δ weight
- up 1.01 pts
- Value
- ₹1,035 Cr
- Δ value
- up ₹105 Cr
- Status
- Added
- Weight
- 8.42%
- Δ weight
- up 0.11 pts
- Value
- ₹600 Cr
- Δ value
- up ₹27.8 Cr
- Status
- Added
- Weight
- 6.43%
- Δ weight
- up 0.36 pts
- Value
- ₹459 Cr
- Δ value
- up ₹40.1 Cr
- Status
- Added
- Weight
- 5.55%
- Δ weight
- down 0.43 pts
- Value
- ₹396 Cr
- Δ value
- down ₹16.3 Cr
- Status
- Trimmed
- Weight
- 4.95%
- Δ weight
- up 0.07 pts
- Value
- ₹353 Cr
- Δ value
- up ₹16.7 Cr
- Status
- Added
- Weight
- 4.41%
- Δ weight
- down 0.13 pts
- Value
- ₹314 Cr
- Δ value
- up ₹2 Cr
- Status
- Added
- Weight
- 4.21%
- Δ weight
- down 0.62 pts
- Value
- ₹300 Cr
- Δ value
- down ₹32.4 Cr
- Status
- Trimmed
- Weight
- 3.96%
- Δ weight
- up 0.65 pts
- Value
- ₹283 Cr
- Δ value
- up ₹54.3 Cr
- Status
- Added
- Weight
- 3.44%
- Δ weight
- up 0.57 pts
- Value
- ₹246 Cr
- Δ value
- up ₹47.7 Cr
- Status
- Added
- Weight
- 3.26%
- Δ weight
- down 0.38 pts
- Value
- ₹232 Cr
- Δ value
- down ₹18.2 Cr
- Status
- Trimmed
- Weight
- 3.00%
- Δ weight
- down 0.20 pts
- Value
- ₹214 Cr
- Δ value
- down ₹6.3 Cr
- Status
- Trimmed
- Weight
- 3.00%
- Δ weight
- down 0.06 pts
- Value
- ₹214 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
- Weight
- 2.90%
- Δ weight
- down 0.44 pts
- Value
- ₹207 Cr
- Δ value
- down ₹23.7 Cr
- Status
- Trimmed
- Weight
- 2.86%
- Δ weight
- down 0.17 pts
- Value
- ₹204 Cr
- Δ value
- down ₹5 Cr
- Status
- Trimmed
- Weight
- 2.85%
- Δ weight
- down 0.12 pts
- Value
- ₹203 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 2.71%
- Δ weight
- down 0.02 pts
- Value
- ₹194 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 2.70%
- Δ weight
- up 0.08 pts
- Value
- ₹192 Cr
- Δ value
- up ₹12.2 Cr
- Status
- Added
- Weight
- 2.60%
- Δ weight
- down 0.19 pts
- Value
- ₹186 Cr
- Δ value
- down ₹6.5 Cr
- Status
- Trimmed
- Weight
- 2.60%
- Δ weight
- down 1.24 pts
- Value
- ₹185 Cr
- Δ value
- down ₹79.5 Cr
- Status
- Trimmed
- Weight
- 2.26%
- Δ weight
- up 0.04 pts
- Value
- ₹161 Cr
- Δ value
- up ₹8.1 Cr
- Status
- Added
- Weight
- 2.05%
- Δ weight
- up 0.06 pts
- Value
- ₹147 Cr
- Δ value
- up ₹9 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 2.05%
- Δ weight
- up 1.28 pts
- Value
- ₹147 Cr
- Δ value
- up ₹93.2 Cr
- Status
- Added
- Weight
- 2.00%
- Δ weight
- down 0.19 pts
- Value
- ₹143 Cr
- Δ value
- down ₹8.4 Cr
- Status
- Trimmed
- Weight
- 1.71%
- Δ weight
- up 0.15 pts
- Value
- ₹122 Cr
- Δ value
- up ₹14.2 Cr
- Status
- Added
- Weight
- 1.33%
- Δ weight
- up 0.28 pts
- Value
- ₹94.6 Cr
- Δ value
- up ₹22.3 Cr
- Status
- Added
- Weight
- 1.11%
- Δ weight
- down 0.11 pts
- Value
- ₹79.4 Cr
- Δ value
- down ₹5 Cr
- Status
- Trimmed
- Weight
- 0.90%
- Δ weight
- down 0.09 pts
- Value
- ₹64.1 Cr
- Δ value
- down ₹4.2 Cr
- Status
- Trimmed
- Weight
- 0.61%
- Δ weight
- down 0.44 pts
- Value
- ₹43.9 Cr
- Δ value
- down ₹29.1 Cr
- Status
- Trimmed
- Weight
- 0.50%
- Δ weight
- up 0.38 pts
- Value
- ₹35.3 Cr
- Δ value
- up ₹27.7 Cr
- Status
- Added
- Weight
- 0.47%
- Δ weight
- down 0.03 pts
- Value
- ₹33.5 Cr
- Δ value
- down ₹64 L
- Status
- Trimmed
- Weight
- 0.44%
- Δ weight
- down 0.02 pts
- Value
- ₹31.3 Cr
- Δ value
- down ₹18 L
- Status
- Trimmed
- Weight
- 0.20%
- Δ weight
- down 0.01 pts
- Value
- ₹14.5 Cr
- Δ value
- down ₹42 L
- Status
- Trimmed
What changed, Jan 2024 to Feb 2024
New New positions (0)
None.
Exited Exited (1)
- Tarsons Products Limitedwas 0.2% · ₹10.8 Cr
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹105 Cr (+1.01% pts)
- Zydus Lifesciences Limitedup ₹54.3 Cr (+0.65% pts)
- Abbott India Limitedup ₹47.7 Cr (+0.57% pts)
- Cipla Limitedup ₹40.1 Cr (+0.36% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jan 2024, the weight rose most in Pharmaceuticals & Biotechnology (+1.4 pts), and fell most in Healthcare Services (−1.0 pts) and Retailing (−0.2 pts).
- Pharmaceuticals & Biotechnology77.4% → 78.9%+1.4 pts
- Healthcare Services18.2% → 17.2%−1.0 pts
- Retailing3.2% → 3.1%−0.2 pts
- Healthcare Equipment & Supplies0.2% → 0.0%exited−0.2 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2021 | Feb 2023 | Aug 2023 | Nov 2023 | Jan 2024 | Feb 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.0% | 76.8% | 77.8% | 76.6% | 77.4% | 78.9% |
| Healthcare Services | 18.3% | 19.7% | 16.3% | 18.2% | 18.2% | 17.2% |
| Retailing | — | 1.6% | 4.7% | 4.0% | 3.2% | 3.1% |
| Pharmaceuticals | 2.4% | 1.6% | 1.1% | 1.1% | 1.0% | 0.9% |
Allocation in Feb 2024change vs Jan 2024
- Pharmaceuticals & Biotechnology (21)78.9%▲ 1.4 pts
- Healthcare Services (8)17.2%▼ 1.0 pts
- Retailing (1)3.1%▼ 0.2 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Feb 2024
2.1%
▲ 1.3 pts vs Jan 2024
- Cash alone
- 2.1%
- cash and net receivables
- A year earlier
- 0.8%
- Feb 2023 · now ▲ 1.3 pts
- Last 12 months
- 0.5% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.